361 related articles for article (PubMed ID: 31915250)
41. Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress.
Walter LA; Lin YH; Halbrook CJ; Chuh KN; He L; Pedowitz NJ; Batt AR; Brennan CK; Stiles BL; Lyssiotis CA; Pratt MR
Biochemistry; 2020 Sep; 59(34):3169-3179. PubMed ID: 31625393
[TBL] [Abstract][Full Text] [Related]
42. The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.
Chiaradonna F; Ricciardiello F; Palorini R
Cells; 2018 Jun; 7(6):. PubMed ID: 29865240
[TBL] [Abstract][Full Text] [Related]
43. Hexosamine biosynthesis and related pathways, protein N-glycosylation and O-GlcNAcylation: their interconnection and role in plants.
Chen YH; Cheng WH
Front Plant Sci; 2024; 15():1349064. PubMed ID: 38510444
[TBL] [Abstract][Full Text] [Related]
44. Cancer metabolism: cross talk between signaling and O-GlcNAcylation.
Ferrer CM; Reginato MJ
Methods Mol Biol; 2014; 1176():73-88. PubMed ID: 25030920
[TBL] [Abstract][Full Text] [Related]
45. Repeated sleep deprivation decreases the flux into hexosamine biosynthetic pathway/O-GlcNAc cycling and aggravates Alzheimer's disease neuropathology in adult zebrafish.
Park J; Kim DY; Hwang GS; Han IO
J Neuroinflammation; 2023 Nov; 20(1):257. PubMed ID: 37946213
[TBL] [Abstract][Full Text] [Related]
46. Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise.
Myslicki JP; Belke DD; Shearer J
Appl Physiol Nutr Metab; 2014 Nov; 39(11):1205-13. PubMed ID: 25203141
[TBL] [Abstract][Full Text] [Related]
47. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis.
Rajamani U; Essop MF
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C139-47. PubMed ID: 20410435
[TBL] [Abstract][Full Text] [Related]
48. GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway.
Kroef V; Ruegenberg S; Horn M; Allmeroth K; Ebert L; Bozkus S; Miethe S; Elling U; Schermer B; Baumann U; Denzel MS
Elife; 2022 Mar; 11():. PubMed ID: 35229715
[TBL] [Abstract][Full Text] [Related]
49. Hexosamine pathway activation improves memory but does not extend lifespan in mice.
Allmeroth K; Hartman MD; Purrio M; Mesaros A; Denzel MS
Aging Cell; 2022 Oct; 21(10):e13711. PubMed ID: 36124412
[TBL] [Abstract][Full Text] [Related]
50. Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase.
Taylor RP; Parker GJ; Hazel MW; Soesanto Y; Fuller W; Yazzie MJ; McClain DA
J Biol Chem; 2008 Mar; 283(10):6050-7. PubMed ID: 18174169
[TBL] [Abstract][Full Text] [Related]
51. The role of O-GlcNAcylation in immunity against infections.
Quik M; Hokke CH; Everts B
Immunology; 2020 Nov; 161(3):175-185. PubMed ID: 32740921
[TBL] [Abstract][Full Text] [Related]
52. O-GlcNAcylation: a pro-survival response to acute stress in the cardiovascular and central nervous systems.
Xue Q; Ji S; Xu H; Yu S
Eur J Med Res; 2024 Mar; 29(1):174. PubMed ID: 38491477
[TBL] [Abstract][Full Text] [Related]
53. The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.
Semba RD; Huang H; Lutty GA; Van Eyk JE; Hart GW
Proteomics Clin Appl; 2014 Apr; 8(3-4):218-31. PubMed ID: 24550151
[TBL] [Abstract][Full Text] [Related]
54. Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein
Chen Y; Zhao X; Wu H
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1911-1924. PubMed ID: 31462094
[TBL] [Abstract][Full Text] [Related]
55. Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death.
Asthana A; Ramakrishnan P; Vicioso Y; Zhang K; Parameswaran R
Mol Cancer Ther; 2018 Oct; 17(10):2226-2237. PubMed ID: 30082471
[TBL] [Abstract][Full Text] [Related]
56. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
[TBL] [Abstract][Full Text] [Related]
57. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
58. Neutrophils exhibit rapid agonist-induced increases in protein-associated O-GlcNAc.
Kneass ZT; Marchase RB
J Biol Chem; 2004 Oct; 279(44):45759-65. PubMed ID: 15322139
[TBL] [Abstract][Full Text] [Related]
59. Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.
Vaillant F; Lauzier B; Ruiz M; Shi Y; Lachance D; Rivard ME; Bolduc V; Thorin E; Tardif JC; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H991-H1003. PubMed ID: 27496881
[TBL] [Abstract][Full Text] [Related]
60. Glutamine deprivation triggers NAGK-dependent hexosamine salvage.
Campbell S; Mesaros C; Izzo L; Affronti H; Noji M; Schaffer BE; Tsang T; Sun K; Trefely S; Kruijning S; Blenis J; Blair IA; Wellen KE
Elife; 2021 Nov; 10():. PubMed ID: 34844667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
